Danielle and Cam speak with Varun Goyal, CEO of Illuminate Health. Varun talks about how better medication management via tele-pharmacy decreases adverse reactions to medications, the future of tele-pharmacy, and the applications of Artificial Intelligence in the field.
“I think in terms of the future of telehealth it is going to be the mix of a hybrid care model based on preferences on the provider and patient side, clinical protocols, insurance companies, and reimbursement of course will have a role there. But talking about the future can’t be truly complete without mentioning AI. How do we customize the time with a pharmacist? How do we let technology make the first pass and have pharmacists really focus on what needs to be done?”
I think in terms.
Varun:The future of telehealth it's gonna be a mix of the, hybrid care models based on
Varun:preferences on provider, patient side, clinical protocols, insurance companies
Varun:and reimbursement will have a role there.
Varun:And then of course this conversation would be incomplete without mentioning
Varun:AI How do we optimize the time of a pharmacist ? How do we let technology
Varun:take a first pass and have pharmacists really focus in on what needs to be done.
Triston:Welcome to a virtual view where we talk about tele-health
Triston:healthcare and everything in between.
Danielle:we're joined today by Varon Goyle the CEO and co-founder of
Danielle:illuminate health to discuss telepharmacy and medication management platforms.
Danielle:Thank you so much for joining us today.
Varun:You bet, Daniel, thanks for having me on.
Danielle:Yeah.
Danielle:Could you give us a quick overview of your background?
Varun:Absolutely.
Varun:Yeah I'm an engineer by background and, just spent a large amount of my career in
Varun:designing software solutions for different companies and in various industries.
Varun:And gravitated towards healthcare over time, just given how complex
Varun:it is and, seemed to be behind the tech adoption curve if you will.
Varun:So yeah, we're no business school for healthcare and been working in healthcare,
Varun:starting out with a role with a company called Hillrom in Ville, Indiana.
Varun:Did that for a couple of years in medical devices and then moved
Varun:up to working close to Carmel at a company called avail in revenue cycle.
Varun:Management and really understanding the reimbursement side of healthcare
Varun:from a provider perspective, as well as a health plan perspective.
Varun:And that's when we had some personal experiences with the medication
Varun:errors that led us to start thinking about med management and how can
Varun:we offer a better experience.
Varun:So that's a little bit about my background.
Danielle:Did that naturally lead into telehealth or was that something you
Danielle:specifically knew that you wanted to bring the medication management into.
Varun:So really, the piece that was interesting to me is that in this day
Varun:and age, we were having an experience like this, where, we were getting
Varun:prescribed the wrong medication or.
Varun:Being prescribed a medication despite documented side effects to
Varun:a medication or allergic reactions.
Varun:We started looking at tools on the market that consumers like us could
Varun:use, and didn't find anything with, I'll call it clinical intelligence
Varun:or true value if you will.
Varun:And and so around that time, I met my co-founder Kal.
Varun:Looking at my background, he started talking to me about all his issues,
Varun:managing his own meds and unexpected side effects and this and that.
Varun:So we had this meeting of the minds where we said, we've talked to enough people.
Varun:We've seen the statistics out there around what's called adverse drug events.
Varun:Where it's either a medication error or other reason.
Varun:And a lot of them are preventable.
Varun:And so we need to do something about this, so that's how we started thinking about.
Varun:And really focusing in on the medication safety piece, but then
Varun:the confusion piece even for someone like me, I was taking an antibiotic.
Varun:I think it was CIN where, because I was researching this project, I
Varun:sat and read through the pamphlet that comes from the pharmacy.
Varun:Which most people don't it's full of medical jargon.
Varun:I also needed a magnifying lens to read the small font.
Varun:But I realized that I should not be taking the medication within
Varun:two hours of having a meal.
Varun:Otherwise it makes the medicine less effective and I'm like,
Varun:why would no one tell me that?
Varun:Stuff like that gets to me.
Varun:And of course, we've all seen our.
Varun:Parents and grandparents age and struggle with, managing the 10 meds.
Varun:And everyone's confused when and how do I take these 10 meds?
Varun:Do I have to take today?
Varun:So that's the way we came to where we are because , over time, we started
Varun:relying on our neighborhood pharmacist.
Varun:To be honest with you.
Varun:And so that's how the thesis came together.
Varun:We said, okay, it'd be satisfying for us.
Varun:If we could use technology to simplify med management for the average, Joe.
Varun:And put the pharmacist at the helm of driving that patient care,
Varun:because, there's such a medication expert and quite the underutilized
Varun:resource underrecognized.
Danielle:Pharmacists are frequently overlooked as a healthcare professional.
Danielle:And I think that's very interesting how you took your own personal
Danielle:experiences, as well as just looking at the needs of what was out there and
Danielle:then moving forward with this project.
Varun:Really what we are trying to do is provide medication management
Varun:as a service led by pharmacists, but enabled by technology.
Varun:And that's where that telehealth piece comes in, where, we want
Varun:everyone to have easy access.
Varun:To, to the right information at the right time.
Varun:Not just digital resources, but then, the consults, the interventions that a
Varun:pharmacist can do the education piece.
Varun:So that's how we've been thinking about it and we started out more
Varun:on the patient side, looking at the challenges they have as we discussed.
Varun:Our recent focus given that, we are connecting the pharmacist with patient.
Varun:Has been on the pharmacist tools as well.
Varun:How do we make it easy for pharmacists to really focus on, patient care
Danielle:Exactly.
Danielle:So we talked a little bit about the risks and benefits, but are there specific
Danielle:risks that exist in maybe a traditional healthcare setting that doing this
Danielle:through telehealth sort of mitigates.
Varun:which is what they're passionate about doing?
Varun:Absolutely.
Varun:So the obvious benefit of telehealth is the access, right?
Varun:The convenience, the ease of being able to consult with a healthcare professional
Varun:cost also, comes into play in terms of having that access as well as timing, so
Varun:with telehealth, you can, potentially even just talk to your provider right away.
Varun:And so that's.
Varun:The a similar benefit from our perspective, in terms of more of that
Varun:pharmacy care management side of things that it's just accessing timely help.
Danielle:And is this something where having this information more
Danielle:readily available to patients?
Danielle:Is that something that impacts health literacy at all?
Varun:Oh, absolutely.
Varun:Yeah.
Varun:And in fact that's a huge reason.
Varun:Why we designed our solution this way.
Varun:We wanted to take some of that work off self care, off the plate
Varun:of either the patient themselves or maybe the family . Caregiver.
Varun:And as I shared recently, even the pharmacist and so a lot of the way
Varun:we've designed our, tech platform.
Varun:And approach is to improve health literacy because as majority of Americans,
Varun:do not have the health literacy.
Varun:I think the last statistic I read was was it 80% do not or
Varun:something drastic like that.
Varun:We focus a lot on, when is the right time to take a given medication?
Varun:And how do you take the medication and so on.
Varun:So that's a big aspect of improving that.
Varun:Let's call it medication literacy, and then, we can we configure the daily
Varun:routine and care plan if you will specific to the patient's condition.
Varun:So that's where some of the disease education comes in as well.
Varun:And hence, all of it goes hand in terms of increasing health literacy.
Varun:Cuz now they've got the educational references and the mobile app for
Varun:the patient or the family caregiver, prompting them, educating them,
Varun:engaging them while also providing easy access to a pharmacist.
Varun:When they have a question apart from the scenarios where pharmacists
Varun:would proactively reach out to.
Danielle:I do think it's interesting that you mentioned like family caregivers, cuz
Danielle:I know that a population that is very dependent on medication is aging adults.
Danielle:And that's a population that again, may not have that health literacy.
Danielle:So I think we talk about involving family caregivers and that kind of stuff.
Danielle:And is that something that is made easier through a telehealth platform like this.
Varun:Absolutely.
Varun:You think about, the caregiver burden as it's called of taking care.
Danielle:Right.
Varun:A loved one.
Varun:It's real, these people are trying to manage somewhat of a professional life
Varun:if it's still possible, along with other aspects of, family home and more.
Varun:And our approach is really, how do we simplify?
Varun:How do we take something off their plate and just make it super easy
Varun:for them to just know that, okay.
Varun:Cameron this is the pill you need to give.
Varun:Your loved one at this time, and this is what it looks like.
Varun:And by the way, give it with a full glass of water.
Varun:And just check it off that you gave it.
Varun:So it's stuff like that.
Varun:And then, if, yeah, if they have a side effect or some question, Cameron
Varun:can now just just chat message the question and the pharmacist can
Varun:respond in a timely manner as compared to Cameron having to call multiple
Varun:places or having the doctor respond within 24 hours and stuff like that.
Cameron:Yeah.
Cameron:That's interesting point too, when you're talking about, how can we.
Cameron:Improve access as well, health literacy, as well as take some of the burden
Cameron:off of some of the caregivers who are working directly with those patients.
Cameron:And one of the big barriers with that is, during the COVID 19 pandemic in
Cameron:telemedicine appointments, providers were able to prescribe directly to patients.
Cameron:Now we don't have anything set in stone.
Cameron:However, it seems to be trending back to, once the COVID 19 pandemic ends,
Cameron:that, the ability to be able to prescribe medication to patients via telemedicine
Cameron:appointment may be in jeopardy.
Cameron:From your perspective, and just, working with patients for telepharmacy, what's
Cameron:some of the benefits of, being able to.
Cameron:Be prescribed the medication via telemedicine appoint.
Varun:You know, back to the point you made earlier, Cameron, I it's more
Varun:of the controlled substances, right?
Varun:That there, needs to be more scrutiny around because unfortunately there's
Varun:the good side and the bad side of it.
Varun:Just like everything else.
Varun:I absolutely, otherwise support the the prescribing over telehealth, again, from
Varun:the standpoint of ease the convenience, the access but obviously, it's a mix.
Varun:Clinical protocols in terms of, does a provider need to actually
Varun:examine you physically in order to comfortably prescribe something as
Varun:well as, patient preferences now where.
Varun:Yeah, let's say that I might be able to get my prescription over telehealth,
Varun:but I'm just used to wanting to see the provider face to face in person.
Varun:And that's just my comfort level.
Varun:So it's, I think we're at that cusp of like you said, where
Varun:telehealth's utilization just, skyrocketed early in the pandemic.
Varun:And then now it's wanna call it plateaued to some degree or come back to maybe.
Varun:Could be the new normal, but I think people are still trying to
Varun:figure out what is that right.
Varun:Hybrid care model
Varun:where,
Cameron:We've had the most use cases with the most variety of telehealth
Cameron:services that we've ever had in the past.
Cameron:And we did that in a panic during the pandemic, cuz that was the only
Cameron:way we could roll out care to people.
Cameron:But now we're moving into this stage where.
Cameron:Does this particular type of service or this particular activity that
Cameron:we're doing with a patient make sense to do in a virtual format?
Cameron:Is it better to do in person?
Cameron:Is it better to do virtual?
Cameron:Is it okay?
Cameron:Both ways?
Cameron:so we're kind of in this weird limbo spot where we're still looking at a lot
Cameron:of different things to see, what's gonna be the method that makes most sense.
Cameron:And it's interesting, you brought up patient choice.
Cameron:I think that's gonna become a much.
Cameron:Bigger deal with care, that's gonna drive what a lot of change will look like in
Cameron:either these virtual first, in person or hybrid what are patients choosing?
Cameron:So if they really want certain services using tele behavioral health, as an
Cameron:example, To be predominantly virtual.
Cameron:That's gonna change the landscape of what behavioral healthcare
Cameron:will look like in the future.
Varun:Absolutely.
Varun:Yeah.
Cameron:But if people maybe are seeking out care for a different
Cameron:condition and they prefer to be seen in person and that's what
Cameron:majority of the people are doing.
Cameron:That's also gonna impact that service line.
Cameron:So it's gonna be interesting to see, how some of those things shake out.
Cameron:But even within the realm of telepharmacy, what do those protocols look like?
Cameron:When it comes to prescribing controlled substances to patients and what
Cameron:would be the most effective approach I think is something that a lot of
Cameron:people still have on their mind and are trying to figure out, sorry.
Danielle:So we talk about patient choice and patient preference, and I
Danielle:think it gets very interesting when we get into the realm of populations that
Danielle:maybe don't have the same access to services things like rural populations.
Danielle:We work a lot with those, or like I said, populations that
Danielle:are aging in place and maybe.
Danielle:Can't get to a provider.
Danielle:I think telehealth and medication management platforms could be a very
Danielle:good sort of avenue for those folks who maybe don't have the luxury of choice
Danielle:to have access to these services.
Varun:Absolutely.
Varun:, transport and the distances to your point is such a big challenge.
Varun:From that perspective, I think what's been interesting in the last couple
Varun:of years is just seeing that tech adoption, if you will, where, up to
Varun:a large degree, it's just smartphone access used to be a challenge.
Varun:Thankfully the Medicaid plans, states and others have made smart phones available
Varun:or tablets in some cases for folks on.
Varun:And then even the tech savviness has really come up on the learning
Varun:curve over the pandemic, because everyone's had to adopt to zoom or
Varun:whatever it might be whether for work or, stay in touch with their family.
Varun:And so I think, we've come a long way in terms of that infrastructure
Varun:and that digital literacy piece.
Varun:Of course, still room to grow, especially in the aging population,
Varun:but I think that's where back to.
Varun:Conversation about the family caregivers, that becomes more relevant
Varun:where, maybe it, it is that grandson or wife or someone who's helping
Varun:the the person with technology.
Varun:Which of course has, become much more simplified than
Varun:what it used to be as well.
Varun:So I think that's really the way we see this going in terms of,
Varun:the rural populations as well.
Varun:And same with the providing value to providers in, in the rural health
Varun:setting as well, where, even they don't have the same level of resources.
Varun:And how can a service like ours provide value to the provider who's already,
Varun:overworked burned out potentially.
Varun:Where, we can take on some of the work of med management, medication education
Varun:and even some of the care coordination that it's involved in, what's called a
Varun:medication reconciliation where, we're trying to verify that this patient who
Varun:was just discharged from a hospital back to their home environment,
Varun:what is their latest and greatest medication list that they should be.
Varun:Because they had meds going into the hospital and then now
Varun:they have new meds as well.
Varun:And even those aspects so that we can then share an updated medication list
Varun:with the provider, with the family, caregiver, and patient just is,
Varun:we've heard is tremendously valuable.
Varun:Yeah.
Danielle:yeah, in my own personal experience, I've had family members
Danielle:with chronic health issues, and I know that even just finding.
Danielle:A complete list of all of those medications can be a real task.
Danielle:And even after that of figuring out what the interactions and the different side
Danielle:effects to be on the lookout for are, can be something that's very difficult without
Danielle:the aid of some sort of platform or having a pharmacist like readily available.
Cameron:I think even with that, we've seen some and you can correct
Cameron:me if I'm wrong, or if I'm making this up, I probably need to go.
Cameron:Get a patent for this, but uh, I've seen commercials for, this machine where
Cameron:you can put multiple medications in it and you can put settings so that for
Cameron:individuals know the particular cadence.
Cameron:Or time of day that they're supposed to be taking certain medications.
Cameron:Now, granted, those are helpful and those can be a, something to
Cameron:use as an assist, but it still doesn't help you with interactions.
Cameron:I'm.
Cameron:Pretty sure they don't tell you.
Cameron:Yeah.
Cameron:You need to eat before you take this medication and some more of
Cameron:the specifics with that, and I'm sure the barrier to entry as far as
Cameron:cost for those are not cheap either.
Cameron:So we've seen, some of those, that are supplements, but not
Cameron:really quite a complete solution to really help people with that.
Cameron:You really do have to have that engage.
Cameron:With a healthcare professional that knows those medications and can
Cameron:really educate that patient to really see positive results, long term.
Varun:Yeah, that's a great point, Cameron, cuz essentially, what you're
Varun:referring to is, is covering sort of one aspect of the challenge, right?
Varun:But there's still other aspects, whether it's the consultation with
Varun:the pharmacist or closing the loop with your doctor or whatever it might
Varun:be where, a lot of us have to work.
Varun:Together nicely or so even on our advisory board, we've got Dr.
Varun:Aiden Fang who, who actually came from a company that did
Varun:those home dispensing devices.
Varun:Really Neat looking robotic device and, dispenses medications on time and so on.
Varun:And yeah, there's, a couple of others in the market, but yeah, to your point
Varun:it provides part of the solution.
Varun:And the cost of entry, is huge, which, over time, yeah.
Varun:Time will tell, will help plans wanna pay for this, as a standard.
Varun:Issue or standard protocol along with then what are the wraparound
Varun:services, the actual medications being delivered, so they can be loaded into
Varun:the device and, all kinds of these other things that, that go into this.
Danielle:Yeah.
Danielle:And we talk about all these different solutions not just the hardware ones,
Danielle:but all the different software stuff too.
Danielle:And I know in telehealth as a whole, and I'm sure in telepharmacy there's
Danielle:an issue with interoperability.
Danielle:Is that something you ever face in your work?
Varun:Absolutely.
Varun:The good news is that there's legislation now in terms of, what's being called the
Varun:in, information blocking that's, trickling down the pipes and, providers, health
Varun:plans are working on making, are, consumer health information available more freely.
Varun:So we've got a couple of different approaches.
Varun:We essentially try and work with.
Varun:Data.
Varun:Every time we're starting to work with a health plan, that's our source of truth.
Varun:If you will.
Varun:Anything we can get from the providers is fantastic.
Varun:Along with, whatever the patient might have as their record, if you will.
Varun:And that's also the beauty of telehealth because now, the patient can just bring
Varun:all their meds from the medicine cabinet.
Varun:Put them on the table right now here, and our pharmacist can see on the camera.
Varun:Okay.
Varun:I see this is what, so I think interoperability is
Varun:an interesting one, I think.
Varun:Yeah.
Varun:Lots to be done there.
Varun:But thankfully, again, things are moving the right direction.
Varun:But but honestly, I think the value of service like this also.
Varun:The fact that you're not just relying on technology so we started a few years
Varun:ago with a ton of mobile apps, right?
Varun:There's an app for this half for that.
Varun:However, engaging you make a kind of freestanding mobile app, people may
Varun:continue or may not continue to use it.
Varun:Research has shown that if you've got a trusted clinician, monitoring what
Varun:you're doing in the mobile app, right?
Varun:Are you taking your meds?
Varun:Are you reporting on your symptoms and side effects and this and that then
Varun:that engagement and that compliance is a lot higher because as you would
Varun:expect, it's you know, that, oh, pharmacist, Joe is watching out for
Varun:me and taking this into account as part of the care decisions for me.
Varun:So I'm gonna be better about, keeping track of these things.
Varun:So I think that also to me is a huge value prop for telehealth service.
Danielle:I feel like with telehealth, we get very caught up in the shiny
Danielle:new technology aspect of that.
Danielle:And sometimes forget that there is a lot of value, obviously in
Danielle:still having medical providers and medical professionals.
Danielle:Be a part of that and that a great value of telehealth is to just connect
Danielle:with those folks, not just to have a fancy camera, what have you, but
Danielle:is to provide those connections and to provide that consistent care?
Cameron:And I think with
Varun:Yeah, for sure.
Varun:The additional tools.
Varun:So what's that saying, right?
Varun:The best technology should not be in, in your environment, it should
Varun:just be the background if you will.
Varun:So technology is just the enabler.
Varun:It can help prompt it can, help you track, give more insight and do how you're doing.
Varun:But it's healthcare.
Varun:We need that human touch, that human contact.
Varun:So absolutely.
Cameron:you can.
Cameron:Catch some of these drug interactions a lot quicker It's
Cameron:not a one size fits all approach.
Cameron:Each patient is gonna interact with a drug differently.
Cameron:That's usually why there's a little bit of trial and error, even when you're trying
Cameron:a new drug for the first time, you don't know exactly how your body's gonna react.
Cameron:So being able to have, that open line of communication with a pharmacist to
Cameron:begin with is gonna be really valuable.
Cameron:But, for some of our listeners who maybe Aren.
Cameron:Very knowledgeable about,
Cameron:what do drug interactions really look like?
Cameron:So how does that impact a patient?
Cameron:Or how does that impact their health outcomes if they are having
Cameron:some of these drug interactions.
Varun:Yeah, absolutely.
Varun:A drug interaction could present itself as a very mild, let's say symptom like
Varun:nausea or stomach upset or something.
Varun:But unfortunately some of the severe drug interactions could, lead you
Varun:to have to go to the ER right away.
Varun:Unfortunately, the debts are also part of the system when it comes to that.
Varun:And there's multiple aspects of adverse drug events as they're
Varun:called, there's drug interactions.
Varun:Yes.
Varun:But then there's also.
Varun:Is this dosage of medication appropriate, given the patient's,
Varun:gender, age, weight, things like that.
Varun:Is there a duplication of therapy going on where it's not just the same drug
Varun:that's being prescribed twice and being taken twice, but the same category of
Varun:drug where maybe the patient is not able to see that, at drug a and drug.
Varun:So they're different, but they're the same category.
Varun:And so they're still causing that duplication.
Varun:So there's multiple aspects of this that, folks have to watch out for, I think
Varun:and then there's the allergies, where, I might be allergic to self on drugs
Varun:for example, or, whatever it might be.
Varun:And then, even food.
Varun:Interactions to some degree, grapefruit juice, for example, with a lot of
Varun:medications, is suggested not to have, or, definite not to have.
Varun:And then, back to your earlier comment, Cameron, I.
Varun:Knowing, which medication's gonna work better.
Varun:I think especially in behavioral health, is a tough one for prescribers to know,
Varun:Hey, which medicine do I start with?
Varun:And then there's conditions where you need more frequent sort of monitoring
Varun:and tight trading of the medication, so adjusting a dose based on how today
Varun:is versus yesterday and so forth.
Varun:So hence.
Varun:More and more the access we at telehealth and that continued sort of engagement
Varun:model versus a once and done, let's say medication consult, if you will.
Varun:Makes sense.
Varun:And last but not least, I think where, pharmaco genomics now can
Varun:play a role as the markers are getting more and more accurate.
Varun:Isn't exactly what you said, in informing some of those prescribing decisions.
Varun:Which medication is gonna be processed better by patient
Varun:Veron versus, Cameron and so on.
Varun:So I think yeah, it's an exciting time.
Cameron:Yeah, and this is, and I'm gonna apologize for my ignorance
Cameron:with that, but I have heard of.
Cameron:Being able to test to see, genetically which medications
Cameron:are gonna be best for you.
Cameron:I met that with a little bit of skeptic skepticism if I was being honest, but
Cameron:just curious from your perspective, where are we at when it comes to that
Cameron:genetic linkage when it comes to certain medications and the effectiveness.
Varun:Yeah, no, absolutely.
Varun:And I was in the same boat, I wanna say about four years ago, when, one
Varun:really started hearing about gen genomics and genetic testing, especially
Varun:with 23 NME and others, right?
Varun:The consumer facing marketing was big in, back.
Varun:Time, if you will.
Varun:But but more specifically, the pharmacogenomic side of it has
Varun:really come a long way as well.
Varun:In, in those years, because not only can your, gen general sort of profile be
Varun:valuable for a physician while they're making prescribing decisions or for
Varun:a pharmacist when they're helping you optimize your medication therapies.
Varun:But then now you can have focus testing from a pharmacogenomic
Varun:profile perspective as well.
Varun:You.
Varun:Focused on a few conditions that, the FDA and CDC have said that yes, these
Varun:are, pretty accurate and worth reviewing.
Varun:So I would absolutely, recommend that at this point.
Varun:Obviously there's a variance in terms of, the vendors that do a good job
Varun:with it and who have got a better reputation, more accuracy, this and
Varun:that, but I that's with everything else,
Cameron:yeah, no, that's really interesting.
Cameron:I had heard of it and I really didn't do a whole lot of digging in it myself
Cameron:to know, okay, how accurate is this?
Cameron:Some that feedback, it's come a long way in a very short period of time.
Cameron:And there's a lot of practical applications with it as well.
Cameron:Do you see, especially with pharmacists, when you're utilizing some of these
Cameron:medications and perhaps, maybe you are treating a patient who is
Cameron:diabetic, and so you're giving them.
Cameron:Drugs that are gonna help them manage their conditions.
Cameron:Do you see applications of like remote patient monitoring to where
Cameron:they're gonna utilize peripheral devices to help, determine what impact
Cameron:perhaps that medication is having on managing that patient's condition?
Varun:Absolutely.
Varun:That's definitely a direction we're headed in, as, as that's a direction
Varun:where the industry in general is going with the reimbursement code,
Varun:of RPM ever since it got available.
Varun:And there's so much value in, in getting that data.
Varun:The, at home device, if you will.
Varun:So blood pressure being the most common one, or checking your glucose readings
Varun:and more and now of course, a lot more sophisticated devices with, what's
Varun:being called a hospital in the home.
Varun:Scenario.
Varun:Even for us app, that's an area where we are starting to look at, how do we tie in
Varun:the data from, an ongoing diagnostic side of it to marry it up with the medication
Varun:management side of it, because then we can have the full picture of, okay,
Varun:Cameron, you say you're taking your, blood pressure meds, but your blood pressure
Varun:reading does not say the same thing.
Varun:Right.
Varun:So it's stuff like that.
Varun:I think that'll really play an important role bringing it all together.
Varun:And part of that is as Danielle was saying before is interoperability and making
Varun:sure that all the data can be structured properly and you get the right insights at
Varun:the right time and be able to intervene.
Danielle:That's all really exciting.
Danielle:And just looking at like the future of telehealth in general,
Danielle:and telepharmacy specifically.
Danielle:Do you have any Thoughts about where we might go in the future in
Danielle:the sort of realm of telepharmacy and medication management platform.
Varun:I think there's a lot of room for providing more
Varun:access and increasing awareness.
Varun:What started out on the Medicare side is MTM medication therapy management,
Varun:even the penetration of just MTM is not that great, across the country.
Varun:So I think there's need for, more awareness and pushing that
Varun:a little bit more so that more people available those services.
Varun:But I think in terms.
Varun:The future of telehealth as we already discussed.
Varun:I think it's gonna be a mix of the, hybrid care models based on preferences
Varun:on both provider, patient side, clinical protocols, obviously insurance companies
Varun:and reimbursement will have a role there.
Varun:I think from a pharmacy care management side, otherwise I think it's.
Varun:How do we optimize the time of a pharmacist as well?
Varun:So lots going into, how do we let technology take a first pass at,
Varun:what should be identified with this patient and have pharmacists really
Varun:focus in on what needs to be done.
Varun:And then that.
Varun:Engagement model, whether it's, for the patient, whether it's a call, it's a text
Varun:it's a mobile app, not really tethering ourselves to one versus the other, I think
Varun:is gonna be interesting as we go forward.
Varun:And then of course this conversation would be incomplete without mentioning
Varun:AI and the role of bots going forward.
Varun:So the conversational AI, which is the most exciting.
Varun:In my mind where, now a bot could be having a conversation,
Varun:with you as a human almost.
Varun:So it's been interesting to see some of the surveys and studies out there where,
Varun:some people enjoy interacting with a text based chat bot versus, a life conversation
Varun:and more , so I think those some of the exciting things developing from a
Varun:virtual care telehealth perspective.
Danielle:The mention of AI, we have a colleague who talks
Danielle:about that quite frequently.
Danielle:So I do like the idea of taking some of the sort of lower level tasks
Danielle:that maybe take up a pharmacist's time and delegating those to an AI.
Danielle:So you have more time to focus on the very important, not that everything
Danielle:is an important, but the more labor intensive things, the things
Danielle:that do require human interaction.
Varun:And honestly, that's the other aspect of where, I get really excited
Varun:because, if over time we can really crowdsource all kinds of these medication.
Varun:Prescriptions, the side effects, the experiences people are having and really
Varun:use AI again, going back to Cameron, your question about the right prescribing
Varun:decisions, off, how did this work for this kind of patient cohort and use
Varun:that data as part of it, but also use that data to help guide the patient
Varun:on an ongoing basis in terms of just.
Varun:Optimizing their medication therapy, simple scenario of, oh yeah.
Varun:You're having some nausea today because you started this medication two days ago.
Varun:And so this is the typical sort of, curve we see of how it settles in and so forth.
Varun:So I think that's definitely the future.
Danielle:Thank you so much for being here today with us.
Danielle:I think we had a great conversation.
Danielle:I really appreciate you taking the time to talk with
Varun:You bet really enjoyed the conversation.
Varun:Thank you again for having me.
Varun:And would love to just use this to get the word out about what we
Varun:are trying to do@illuminate.health and uh, you know, all of us have
Varun:aging parents and folks who might.
Varun:Benefit from the service.
Varun:So thank you again.
Danielle:thanks so much.
Caroline Yoder:Thank you for listening to a virtual view.
Caroline Yoder:You can find more information about today's episode in the show notes below.
Caroline Yoder:If you would like to support our podcast, please rate and review us
Caroline Yoder:on your favorite podcast player.
Caroline Yoder:Do you have any questions or topics you'd like us to discuss?
Caroline Yoder:If so, contact us at info at UMTRC dot org or through the
Caroline Yoder:form found in the show notes.
Caroline Yoder:Also, we'd like to give a special thanks to our editor.
Caroline Yoder:Finally a special thanks to the health resources and service administration.
Caroline Yoder:Also known as HERSA.
Caroline Yoder:Our podcast series of virtual view is sponsored in part by hearses telehealth
Caroline Yoder:resource center program, which is under hers is office of the administrator and
Caroline Yoder:the office for the advancement of tele.
Caroline Yoder:The content and conclusions of this podcast are those of Cameron hilt of the
Caroline Yoder:UMTRC and should not be construed as the official policy of, or the position of
Caroline Yoder:nor should any endorsements be inferred by HERSA, HHS, or the U S government.
Caroline Yoder:Thanks for listening and have a . Great day.